Growing Evidence of Increased Cancer Risk in Psoriasis Patients

Often triggered by stress, infections, and certain medications, the chronic inflammatory skin condition psoriasis affects up to 125 million patients worldwide. The skin disorder has been linked to decreased quality of life, along with an increased risk of comorbid conditions. In recent years, the association between psoriasis and risk of cancer has been controversial with …

The Role of Gut Microbiome in Psoriasis

The body of clinical literature concerning psoriasis is continuously growing as the disease’s many unsolved mysteries continue to puzzle investigators. While research has yet to uncover a cure for psoriasis, significant developments in recent years have enabled the development of therapies that can drastically mitigate associated symptoms and improve patient quality of life. A new …

The Future of the Atopic Dermatitis Market

Although sometimes conflated as one condition, psoriasis and atopic dermatitis (AD) differ from each other in clinical presentation yet share similar guidelines, mental health repercussions, and therapeutic options. As psoriasis-focused treatment modalities have multiplied over the past few years due to a spike in prevalence, similar growth is currently being witnessed in the AD medication …

Psoriasis and Its Treatment with New Generation Biologics

By: Sangeeta Chakraborty, Ph.D. | Research Associate at National Jewish Health Overview Psoriasis is one of the most common non-communicable skin disorders with a worldwide prevalence of about 2% but can vary from 0.5 to 11%, depending on the geographic region. Since psoriasis pathogenesis is quite complex and the exact mechanisms of its cause are …